机译:FC特征在艾滋病毒感染妇女中介导IgG的选择性胎盘转移
Duke Univ Dept Mol Genet &
Microbiol Med Ctr Durham NC 27710 USA;
Fred Hutchinson Canc Res Ctr Seattle WA 98109 USA;
Duke Univ Duke Human Vaccine Inst Med Ctr Durham NC 27710 USA;
North Carolina State Univ Dept Mol Biomed Sci Coll Vet Med Raleigh NC 27607 USA;
MIT &
Harvard Ragon Inst Massachusetts Gen Hosp Cambridge MA 02139 USA;
Dartmouth Coll Thayer Sch Engn Hanover NH 03755 USA;
North Carolina State Univ Dept Mol Biomed Sci Coll Vet Med Raleigh NC 27607 USA;
Duke Univ Duke Human Vaccine Inst Med Ctr Durham NC 27710 USA;
Duke Univ Duke Human Vaccine Inst Med Ctr Durham NC 27710 USA;
Harvard TH Sch Publ Hlth Dept Epidemiol Boston MA 02115 USA;
MIT &
Harvard Ragon Inst Massachusetts Gen Hosp Cambridge MA 02139 USA;
Dartmouth Coll Thayer Sch Engn Hanover NH 03755 USA;
North Carolina State Univ Dept Mol Biomed Sci Coll Vet Med Raleigh NC 27607 USA;
Duke Univ Duke Human Vaccine Inst Med Ctr Durham NC 27710 USA;
Duke Univ Dept Mol Genet &
Microbiol Med Ctr Durham NC 27710 USA;
机译:FC特征在艾滋病毒感染妇女中介导IgG的选择性胎盘转移
机译:Certolizumab聚乙二醇不结合新生儿Fc受体(FcRn):FcRn介导的体外转细胞作用和离体人胎盘移植的后果
机译:M281,抗FCRN抗体,抑制了人的胎儿胎盘灌注模型中的IgG转移
机译:HL161,一种新型抗FCRN抗体,作为致病IgG介导的自身免疫疾病的新治疗选择
机译:新生儿Fc受体:FcRn(胎盘转移)的研究。
机译:Fc特征介导HIV感染妇女中IgG的选择性胎盘转移
机译:从HIV感染和未感染的妇女到未感染的婴儿的抗B组链球菌IgG抗体亚类的胎盘转移